{"title":"过去10年全球肌肉减少症和癌症的趋势:文献计量学分析。","authors":"Ruoshuang Liu, Menghuan Wu, Xia Cheng, Chundi Zhou, Caiqin Cheng, Lijun Feng, Yirong Shen","doi":"10.1007/s12672-025-03185-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Sarcopenia is common among patients with cancer. The alterations in the internal milieu of cancer patients, coupled with the adverse effects of antineoplastic therapies, markedly augment the susceptibility to sarcopenia. We aimed to clarify the current research status and investigate future trends in sarcopenia and cancer research.</p><p><strong>Methods: </strong>Publications on sarcopenia and cancer from the past decade were retrieved from the Web of Science database. VOSviewer, CiteSpace, and Bibliometrix R package were used for visualization analysis.</p><p><strong>Results: </strong>A total of 3749 publications were retrieved between 2014 and 2023. These publications were written by 21,507 authors affiliated with 4068 organizations in 76 countries/regions. Japan, the United States, and China constituted the primary contributors to the majority of the publications. The top three research institutions with the highest outputs in this field were the University of Alberta, Wenzhou Medical University, and Maastricht University. The Journal of Cachexia Sarcopenia and Muscle served as the pivotal and most cited journal in this field. Baracos VE from the University of Alberta was the author with the most publications. \"Sarcopenic obesity\", \"Radiomics\", and \"Neutrophil/lymphocyte ratio\" were highly focused topics in current research.</p><p><strong>Conclusion: </strong>This study conducted the first bibliometric analysis of literature on sarcopenia and cancer. A systematic analysis of the present research status and emerging trends in this field provides important references for future research.</p>","PeriodicalId":11148,"journal":{"name":"Discover. Oncology","volume":"16 1","pages":"1358"},"PeriodicalIF":2.9000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12271044/pdf/","citationCount":"0","resultStr":"{\"title\":\"Global trends in sarcopenia and cancer over the past 10 years: a bibliometric analysis.\",\"authors\":\"Ruoshuang Liu, Menghuan Wu, Xia Cheng, Chundi Zhou, Caiqin Cheng, Lijun Feng, Yirong Shen\",\"doi\":\"10.1007/s12672-025-03185-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Sarcopenia is common among patients with cancer. The alterations in the internal milieu of cancer patients, coupled with the adverse effects of antineoplastic therapies, markedly augment the susceptibility to sarcopenia. We aimed to clarify the current research status and investigate future trends in sarcopenia and cancer research.</p><p><strong>Methods: </strong>Publications on sarcopenia and cancer from the past decade were retrieved from the Web of Science database. VOSviewer, CiteSpace, and Bibliometrix R package were used for visualization analysis.</p><p><strong>Results: </strong>A total of 3749 publications were retrieved between 2014 and 2023. These publications were written by 21,507 authors affiliated with 4068 organizations in 76 countries/regions. Japan, the United States, and China constituted the primary contributors to the majority of the publications. The top three research institutions with the highest outputs in this field were the University of Alberta, Wenzhou Medical University, and Maastricht University. The Journal of Cachexia Sarcopenia and Muscle served as the pivotal and most cited journal in this field. Baracos VE from the University of Alberta was the author with the most publications. \\\"Sarcopenic obesity\\\", \\\"Radiomics\\\", and \\\"Neutrophil/lymphocyte ratio\\\" were highly focused topics in current research.</p><p><strong>Conclusion: </strong>This study conducted the first bibliometric analysis of literature on sarcopenia and cancer. A systematic analysis of the present research status and emerging trends in this field provides important references for future research.</p>\",\"PeriodicalId\":11148,\"journal\":{\"name\":\"Discover. Oncology\",\"volume\":\"16 1\",\"pages\":\"1358\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-07-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12271044/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Discover. Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12672-025-03185-9\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Discover. Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12672-025-03185-9","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
背景:骨骼肌减少症在癌症患者中很常见。癌症患者体内环境的改变,加上抗肿瘤治疗的不良反应,显著增加了对肌肉减少症的易感性。我们旨在阐明肌少症和癌症研究的现状和未来趋势。方法:从Web of Science数据库中检索近十年来有关肌肉减少症和癌症的出版物。使用VOSviewer、CiteSpace和Bibliometrix R软件包进行可视化分析。结果:2014 - 2023年共检索到文献3749篇。这些出版物由76个国家/地区的4068个组织的21,507位作者撰写。日本、美国和中国是大多数出版物的主要贡献者。该领域产出最高的前三名研究机构分别是阿尔伯塔大学、温州医科大学和马斯特里赫特大学。《恶病质肌少症与肌肉杂志》是该领域最重要和被引用最多的杂志。阿尔伯塔大学的Baracos VE是发表论文最多的作者。“肌少性肥胖”、“放射组学”和“中性粒细胞/淋巴细胞比率”是目前研究的热点话题。结论:本研究首次对肌肉减少症与癌症的文献进行了计量学分析。系统分析该领域的研究现状和发展趋势,为今后的研究提供重要参考。
Global trends in sarcopenia and cancer over the past 10 years: a bibliometric analysis.
Background: Sarcopenia is common among patients with cancer. The alterations in the internal milieu of cancer patients, coupled with the adverse effects of antineoplastic therapies, markedly augment the susceptibility to sarcopenia. We aimed to clarify the current research status and investigate future trends in sarcopenia and cancer research.
Methods: Publications on sarcopenia and cancer from the past decade were retrieved from the Web of Science database. VOSviewer, CiteSpace, and Bibliometrix R package were used for visualization analysis.
Results: A total of 3749 publications were retrieved between 2014 and 2023. These publications were written by 21,507 authors affiliated with 4068 organizations in 76 countries/regions. Japan, the United States, and China constituted the primary contributors to the majority of the publications. The top three research institutions with the highest outputs in this field were the University of Alberta, Wenzhou Medical University, and Maastricht University. The Journal of Cachexia Sarcopenia and Muscle served as the pivotal and most cited journal in this field. Baracos VE from the University of Alberta was the author with the most publications. "Sarcopenic obesity", "Radiomics", and "Neutrophil/lymphocyte ratio" were highly focused topics in current research.
Conclusion: This study conducted the first bibliometric analysis of literature on sarcopenia and cancer. A systematic analysis of the present research status and emerging trends in this field provides important references for future research.